NATASHA MELTON: Open Payments
NPI 1972198372 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 17 payments from 11 companies in 2025. Trend: 2023 $157 · 2024 $141 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $120 |
| ABBVIE INC. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Novo Nordisk Inc | 2 | $35 |
| PFIZER INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, CAPLYTA, VRAYLAR, NURTEC ODT, QULIPTA, AIRSUPRA, Ozempic, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
